​

Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?


OverviewForecastFinancialsChart

Jasper Therapeutics Ownership Summary


Jasper Therapeutics is owned by 54.01% institutional investors, 2.55% insiders, and 43.44% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 13.92% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJasper Therapeutics54.01%2.55%43.44%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Velan capital investment management lp2.67M13.92%$2.34M
Millennium management1.62M8.44%$1.42M
Vanguard group1.33M8.00%$2.43M
Acorn capital advisors1.41M7.36%$1.24M
Kingdon capital management1.35M7.05%$1.18M
Affinity asset advisors1.85M6.45%$1.07M
Qiming u.s. ventures management928.96K6.18%$2.21M
Rock springs capital management lp1.10M5.74%$964.46K
Vanguard capital management1.17M4.08%$679.77K
Carlyle group1.07M3.72%$618.39K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Qiming u.s. ventures management928.96K3.97%$2.21M
Lion point capital, lp465.00K2.44%$407.43K
Velan capital investment management lp2.67M1.46%$2.34M
Acorn capital advisors1.41M0.35%$1.24M
Kingdon capital management1.35M0.13%$1.18M
Rock springs capital management lp1.10M0.06%$964.46K
Affinity asset advisors1.85M0.04%$1.07M
Diker management35.00K0.03%$30.67K
Quarry lp131.53K0.02%$115.25K
Armistice capital348.00K0.01%$828.24K

Top Buyers

HolderShares% AssetsChange
Affinity asset advisors1.85M0.04%1.85M
Kingdon capital management1.35M0.13%1.35M
Millennium management1.62M0.00%543.75K
Verition fund management404.99K0.00%404.99K
Armistice capital348.00K0.01%348.00K

Top Sellers

HolderShares% AssetsChange
Goldman sachs group---1.75M
Woodline partners lp---1.04M
Propel bio management---1.03M
T. rowe price investment management---964.75K
Braidwell lp---714.66K

New Positions

HolderShares% AssetsChangeValue
Affinity asset advisors1.85M0.04%1.85M$1.07M
Verition fund management404.99K0.00%404.99K$234.90K
Armistice capital348.00K0.01%348.00K$828.24K
Landscape capital management236.64K0.01%236.64K$137.25K
Barclays61.53K-61.53K$35.69K

Sold Out

HolderChange
Rossby financial, lcc-2.00
Optiver b.v.-7.00
Sterling capital management-12.00
Wolff wiese magana-15.00
Coldstream capital management-38.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20265517.02%15,498,77629.14%543.09%28133.33%4-73.33%
Jun 30, 202647-21.67%12,001,864-24.10%411.37%12-57.14%1515.38%
Mar 31, 202613-77.59%2,543,150-86.77%130.10%6-81.82%4-63.64%
Dec 31, 20257-89.06%1,540,911-92.35%90.05%3-90.91%2-88.89%
Sep 30, 202512-80.33%3,749,017-66.07%240.46%6-81.82%3-78.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc581.54K3.85%-
Vanguard Total Stock Mkt Idx Inv833.39K2.98%-
Vanguard Morn Total Stk Mkt Idx Investor833.39K2.98%-
Vanguard MStar Total Stk Mkt Idx Invest833.39K2.50%-
Franklin Biotechnology Discv A(acc)USD339.25K2.26%-
iShares Russell 2000 ETF285.63K1.90%-
HBM Healthcare Investments AG Ord250.00K1.67%-
T. Rowe Price U.S. SC Value Eq Tr-Z245.81K1.64%217.41K
T. Rowe Price Small-Cap Value394.02K1.41%-154.27K
Fidelity Select Health Care208.04K1.39%208.04K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 20, 2026Ros Matthew E Chief Operating OfficerBuy-
Jul 20, 2026Crutcher Patrick J-Buy-
Sep 22, 2025WIGGANS THOMAS G-Buy$99.63K
Sep 22, 2025WIGGANS THOMAS G-Buy$119.72K
Sep 22, 2025Lucas Svetlana-Buy$58.40K

Insider Transactions Trends


DateBuySell
2026 Q32-
2026 Q1--
2025 Q38-
2025 Q2--
2025 Q1--

JSPR Ownership FAQ


Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 54.01%, followed by 2.55% insiders and 43.44% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 181.42%, which Jasper Therapeutics falls below.

Who owns the most shares of Jasper Therapeutics?

Jasper Therapeutics’s largest shareholders are Velan capital investment management lp (2.67M shares, 13.92%), Millennium management (1.62M shares, 8.44%), and Vanguard group (1.33M shares, 8.00%). Together, they hold 30.36% of Jasper Therapeutics’s total shares outstanding.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.97% of its assets in 928.96K Jasper Therapeutics shares, valued at 2.21M$.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools